Trial intelligence / Profile preview

TQ-B3101 in ROS1-positive NSCLC

CTR20191078Phase 2Completed

Sponsor

Chia Tai-Tianqing Pharmaceutical Group

Start

Jun 2019

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1